Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2339345 crossover study in chronic idiopathic cough
2012-004891-20Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GSK2339345 in chronic idiopathic cough (CIC) and chronic cough (2 arms), sponsored by GSK. Primary endpoint: Total cough counts. Started Jun 2013; status: completed.
02
Drugs
GSK2339345
03
Conditions
chronic idiopathic cough (CIC)chronic cough
Beyond the preview
Go deeper on 2012-004891-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004891-20.